Location: Home > Pharma China Web Edition
  • search
  • go
  • News
  • 1/11/2025NHSA Issues Announcement on Revisions to Certain Drug Information in t...
  • 1/11/2025CDE Issues the List of Reference Formulations for GQCE Studies (89th B...
  • 1/11/2025NMPA Holds the 2025 National Drug Supervision Work Conference
  • 1/11/2025Bayer Initiates Patent Infringement Lawsuit Against Hengrui Medicine i...
  • 1/11/2025BrainAurora Debuts on Hong Kong Stock Exchange as First Neurotech IPO ...
  • 1/7/2025Cure Genetics Secures Series B Financing to Drive CGT Innovations
  • 1/7/2025Junshi Secures NMPA Approval for Toripalimab in 2nd-Line Melanoma Trea...
  • 1/7/2025Gene Vector Secures Strategic Financing
  • 1/7/2025Insilico Medicine Secures Over $100M in Equity Financing to Advance AI...
  • 1/6/2025NHC Issues Guidelines for Clinical Use of New Anticancer Drugs (2024 E...
  • 1/6/2025Solasia Pharma Partners with GenSci to Boost Sales of Episil in China
  • 1/6/2025I-Mab Reprioritizes Pipeline and Halts CD73 Development
  • 1/6/2025WuXi Bio Divests Irish Vaccine Facility to Merck Amid Potential U.S. R...
  • 1/6/2025GSK's Nucala Gains Expanded Approval in China for CRSwNP Treatment
  • 1/6/2025China Launches Action Plan to Tackle Dementia amid Aging Population Ch...
  • 1/6/2025CDE Issues the List of Reference Formulations for GQCE Studies (88th B...
  • 1/6/2025NMPA Withdraws Registration of All Belladonna Sulfobenzide Tablets
  • 1/6/2025State Council Issues New Policy Document on Deepens Reform to Strength...
  • 1/6/2025Chinese Researchers Use AI to Accelerates Discovery of Potential Glauc...
  • 1/3/2025Recent Official and Executive Moves
  • 1/3/2025Platinum Life Receives Conditional Approval for China's First Stem Cel...
  • 1/3/2025Prime Gene Therapeutics Completes Over CNY 300M in Series B Financing
  • 1/3/2025Gilead's Sunlenca (lenacapavir) Receives Marketing Approval in China
  • 1/3/2025Eli Lilly China Launches Zepbound (tirzepatide) for Diabetes and Weigh...
  • 1/3/2025Astellas' Vyloy (zolbetuximab) Receives Marketing Approval in China fo...
  • 1/3/2025HighLightHill Pharma Secures CNY 150M in Series Pre-C Financing
  • 1/3/2025CDE Issues the Technical Guidelines for Clinical Pharmacology Research...
  • 1/3/2025CDE Publicizes the List of Reference Formulations for GQCE Studies (90...
  • 1/3/2025NMPA Issues Annexes for Pharmaceutical Excipients and Packaging Materi...
  • 1/3/2025NMPA Withdraws Registration for Belladonna Sulfabenzamide Tablets
  • Page:15/47 Total number of articles:1389: [First][<<] [13] [14] [15] [16] [17] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group